The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey

Bulur I., BÜLBÜL BAŞKAN E., Ozdemir M., Balevi A., Goncu E. K., Altunay I., ...More

ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, vol.27, no.3, pp.121-126, 2018 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 3
  • Publication Date: 2018
  • Doi Number: 10.15570/actaapa.2018.25
  • Journal Name: ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
  • Page Numbers: pp.121-126
  • Keywords: chronic spontaneous urticaria, omalizumab, dermatology life quality, UAS(7), side effects, QUALITY-OF-LIFE, INDUCIBLE URTICARIA, DISEASE-ACTIVITY, THERAPY, VALIDATION, MANAGEMENT, INDEX, IGE
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Introduction: This study used real-world data to evaluate the effectiveness and reliability of omalizumab in treating recalcitrant chronic spontaneous urticaria in Turkish patients.